Novel Therapeutics in Ovarian Cancer: Expanding the Toolbox
Despite high response rates to initial therapy, most patients with ovarian cancer will ultimately recur and go on to develop resistance to standard treatments. Novel therapies have been developed to overcome drug resistance and alter the tumor immune microenvironment by targeting oncogenic pathways,...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2023-12-01
|
| Sarja: | Current Oncology |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/1718-7729/31/1/7 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|